Europe Oncology Biosimilars Market Expected to Be Valued at

Caption: Italy accounted for larger revenue share in Europe oncology biosimilars market with moderate CAGR. Supportive care therapy for oncology is driving the Italy market, launch of mAb biosimilars by market players are expected to drive the market over the

Credit: Precision Business Insights